| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 79,730000 | 10/07/2025 | -4,35% | -26,56% | * |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | BIOTECNOLOGÍA | 56,819541 | 10/07/2025 | -12,66% | -32,06% | * |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | BIOTECNOLOGÍA | 55,780000 | 10/07/2025 | -12,71% | -32,25% | * |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 56,110000 | 10/07/2025 | -4,40% | -26,73% | * |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | MIXTO AGRESIVO GLOBAL | 122,040000 | 10/07/2025 | -1,65% | 15,34% | *** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | MIXTO AGRESIVO GLOBAL | 121,786660 | 10/07/2025 | -1,67% | 15,38% | *** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | MIXTO AGRESIVO GLOBAL | 90,410000 | 10/07/2025 | -1,65% | 4,65% | * |
| JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | MIXTO AGRESIVO GLOBAL | 92,100000 | 10/07/2025 | -4,45% | -2,61% | * |
| JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | MIXTO AGRESIVO GLOBAL | 137,870000 | 10/07/2025 | -1,27% | 17,95% | **** |
| JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | MIXTO AGRESIVO GLOBAL | 113,010000 | 10/07/2025 | -1,99% | 13,09% | ** |
